Praxis Precision Medicines elects Jill DeSimone to Board as Class I director

Praxis Precision Medicines, Inc.

Jill DeSimone elected to Board as Class I director effective May 23, 2022.
Board determined DeSimone is independent under Nasdaq listing standards.
DeSimone to receive compensation per company's Non-Employee Director Compensation Policy.
No related person transactions or arrangements exist with DeSimone.
DeSimone entered into standard indemnification agreement with the company.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jill DeSimone

Class I director

PRAX · Praxis Precision Medicines, Inc.

Effective: 2022-05-23
Filed: May 23, 2022, 7:59 PM ET

elected Jill DeSimone to the Board as a Class I director, effective May 23, 2022

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Jill DeSimone was elected as Class I director at Praxis Precision Medicines, Inc..

Action: elected
Role: Class I director

Exact text from the filing

elected Jill DeSimone to the Board as a Class I director, effective May 23, 2022

View on SEC.gov

Praxis Precision Medicines, Inc. filing history →

Source: SEC EDGAR

accession 0001689548-22-000051

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.